Laboratory Billing Staffing Shortages: Why More Labs Are Outsourcing Revenue Cycle Management Laboratories across the country are facing a growing operational challenge: finding and retaining qualified laboratory billing staff. What was once considered a back-office function has become one of the most critical and difficult positions to fill in the laboratory industry. From clinical labs and pathology groups to molecular and toxicology laboratories, many organizations are struggling with staffing shortages, employee turnover, payer complexity, and increasing billing compliance demands.
The claim went out clean. The test was ordered. The patient qualified. And then the denial arrived anyway. If that sequence sounds familiar, your lab is likely losing revenue to a coverage gap that your current billing system cannot see. Local Coverage Determinations and National Coverage Determinations govern whether Medicare will pay for a test, under what circumstances, and with what documentation attached. When those rules are not built into your billing workflow, the errors do not announce themselves. They hide inside an aging AR report and a denial pile that keeps growing.
The Importance of Patient Engagement: Why They - And You - Need It
Learn why patient engagement is a necessity and how you can master it within your practice.
In an industry filled with legacy systems, rigid workflows, and software that often forces laboratories to work around its limitations, TrueMed LIS takes a different approach. TrueMed LIS is a modern laboratory information system built around one simple idea: the LIS should adapt to the lab — not the other way around. For years, TrueMed LIS has supported diagnostic laboratories by helping them launch new testing programs, connect critical systems, improve efficiency, and manage complex workflows. While many vendors rely heavily on marketing, TrueMed LIS has grown through real client results, long-term trust, and word-of-mouth referrals from labs that needed their system to simply work.
The first half of 2026 has introduced one of the most aggressive regulatory and reimbursement shifts the laboratory industry has seen in years. New CMS requirements, expanded FDA oversight, digital CLIA enforcement, evolving payer edits, and rapid adoption of AI-driven revenue cycle management are all arriving at once. For many labs, the financial pressure is not theoretical. It is already showing up in denial rates, delayed reimbursements, and rising operational costs.
The laboratory industry is entering a period of major operational and financial change. Recent CMS and FDA regulatory updates are beginning to reshape how laboratories manage compliance, billing, and reimbursement, and the effects are not theoretical. For many labs, increased denials, delayed reimbursements, expanded documentation requests, and tighter payer scrutiny are already showing up in the numbers.
Clinical laboratories are operating in a much tighter enforcement environment than they were a few years ago. The Department of Justice continues to focus on healthcare fraud, False Claims Act liability, kickback arrangements, medically unnecessary testing, and billing patterns that suggest revenue is being generated without enough compliance control behind it.
Medical Billing / RCM | Laboratory
For clinical laboratories, compliance risk is no longer confined to the legal department. It is now a core financial, operational, and enterprise risk.
Medical Billing / RCM | Laboratory
Laboratory reimbursement is back in the spotlight and the stakes are higher than ever before.